EMBC
Embecta Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.70
+10.12%Forward multiples
Based on analyst estimates
- P/E forward
- 3.71x
- P/E 2026E
- 3.61x
- P/E 2027E
- 3.76x
- P/E 2028E
- 3.40x
- P/S forward
- 0.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.49x
- PEG TTM
- 0.21x
- Price / book
- -0.62x
- Price / sales
- 0.37x
- Price / cash flow
- 2.18x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 1.64x
- EV / EBITDA
- 6.27x
- EV / EBIT
- 6.58x
- Market cap
- $379.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026